{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:31:52Z","timestamp":1780515112923,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00105-012-2518-5","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T09:00:44Z","timestamp":1371546044000},"page":"494-499","source":"Crossref","is-referenced-by-count":3,"title":["Topische Therapie der Rosazea","Topical therapy of rosacea"],"prefix":"10.1007","volume":"64","author":[{"given":"H.","family":"Sch\u00f6fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"key":"2518_CR1","first-page":"149","volume":"80","author":"Allen","year":"2007","unstructured":"Allen KJ, Davis CL, Billings SD, Mousdicas N (2007) Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin. Cutis 80(2):149\u2013151","journal-title":"Cutis"},{"key":"2518_CR2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4632.2004.02130.x","volume":"44","author":"Altinyazar","year":"2005","unstructured":"Altinyazar HC, Koca R, Tekin NS, Esturk E (2005) Adapalene vs. metronidazole gel for the treatment of rosacea. Int J Dermatol 44:252\u2013255","journal-title":"Int J Dermatol"},{"key":"2518_CR3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archderm.140.4.457","volume":"140","author":"Antille","year":"2004","unstructured":"Antille C, Saurat J-H, L\u00fcbbe J (2004) Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 140:457\u2013460","journal-title":"Arch Dermatol"},{"key":"2518_CR4","unstructured":"AWMF-Leitlinie Rosazea 013\/065: http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/013-065l_S1_Rosazea_2013-03_01.pdf"},{"key":"2518_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0190-9622(03)02157-1","volume":"50","author":"Bamford","year":"2004","unstructured":"Bamford JT, Elliott BA, Haller IV (2004) Tacrolimus effect on rosacea. J Am Acad Dermatol 50:107\u2013108","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","volume":"43","author":"Breneman","year":"2004","unstructured":"Breneman D, Savin R, VandePol C et al (2004) Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of moderate to severe rosacea. Int J Dermatol 43:381\u2013387","journal-title":"Int J Dermatol"},{"key":"2518_CR7","first-page":"333","volume":"11","author":"Chang","year":"2012","unstructured":"Chang AL, Alora-Palli M, Lima XT et al (2012) A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2\u2009% and tretinoin 0.025\u2009% combination gel for the treatment of acne rosacea over 12 weeks. J Drugs Dermatol 11:333\u2013339","journal-title":"J Drugs Dermatol"},{"key":"2518_CR8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2005.06404.x","volume":"152","author":"Chu","year":"2005","unstructured":"Chu CY (2005) The use of 1\u2009% pimecrolimus cream for the treatment of steroid-induced rosacea. Br J Dermatol 152:396\u2013399","journal-title":"Br J Dermatol"},{"key":"2518_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","volume":"51","author":"Crawford","year":"2004","unstructured":"Crawford GH, Pelle MT, James WD (2004) Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51:327\u2013341","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1540-9740.2005.03740.x","volume":"4","author":"Crawford","year":"2005","unstructured":"Crawford KM, Russ B, Bostrom P (2005) Pimecrolimus for treatment of acne rosacea. Skinmed 4:147\u2013150","journal-title":"Skinmed"},{"key":"2518_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00015550510043975","volume":"86","author":"Cunha","year":"2008","unstructured":"Cunha PR, Rossi AB (2008) Pimecrolimus cream 1\u2009% is effective in a case of granulomatous rosacea. Acta Derm Venereol 86:71\u201372","journal-title":"Acta Derm Venereol"},{"key":"2518_CR12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","volume":"134","author":"Dahl","year":"1998","unstructured":"Dahl MV, Katz HI, Krueger G et al (1998) Topical metronidazole maintains remissions of rosacea. Arch Dermatol 134:679\u2013683","journal-title":"Arch Dermatol"},{"key":"2518_CR13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1067\/mjd.2001.116219","volume":"45","author":"Dahl","year":"2001","unstructured":"Dahl MV, Jarratt M, Kaplan D et al (2001) Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 45:723\u2013730","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR14","first-page":"16","volume":"5","author":"De","year":"1995","unstructured":"De Bersaques J (1995) Historical notes on (acne) rosacea. Eur J Dermatol 5:16\u201322","journal-title":"Eur J Dermatol"},{"key":"2518_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656566.5.1.5","volume":"5","author":"Del","year":"2004","unstructured":"Del Rosso JQ (2004) Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother 5:5\u201313","journal-title":"Expert Opin Pharmacother"},{"key":"2518_CR16","first-page":"67","volume":"88","author":"Del","year":"2011","unstructured":"Del Rosso JQ, Bhatia N (2011) Azelaic acid gel 15\u2009% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. Cutis 88:67\u201372","journal-title":"Cutis"},{"key":"2518_CR17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PRS.0b013e3181c83192","volume":"125","author":"Draelos","year":"2010","unstructured":"Draelos ZD (2010) Active agents in common skin care products. Plast Reconstr Surg 125:719\u2013724","journal-title":"Plast Reconstr Surg"},{"key":"2518_CR18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","volume":"139","author":"Elewski","year":"2003","unstructured":"Elewski BE, Fleischer AB Jr, Pariser DM (2003) A comparison of 15\u2009% azelaic acid gel and 0.75\u2009% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 139:1444\u20131450","journal-title":"Arch Dermatol"},{"key":"2518_CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","volume":"130","author":"Ertl","year":"1994","unstructured":"Ertl GA, Levine N, Kligman AM (1994) A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 130:319\u2013324","journal-title":"Arch Dermatol"},{"key":"2518_CR20","unstructured":"Ettm\u00fcller M (1690) Operum omnium medico phisicorum. Amaulry, Lyon"},{"key":"2518_CR21","first-page":"1","volume":"17","author":"Fallen","year":"2012","unstructured":"Fallen RS, Gooderham M (2012) Rosacea: update on management and emerging therapies. Skin Therapy Lett 17:1\u20134","journal-title":"Skin Therapy Lett"},{"key":"2518_CR22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0190-9622(99)70022-8","volume":"41","author":"Forstinger","year":"1999","unstructured":"Forstinger C, Kittler H, Binder M (1999) Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol 41(5 Pt 1):775\u2013777","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","volume":"166","author":"Fowler","year":"2012","unstructured":"Fowler J, Jarratt M, Moore A et al (2012) Once-daily topical brimonidine tartrate gel 0.5\u2009% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol 166:633\u2013641","journal-title":"Br J Dermatol"},{"key":"2518_CR24","first-page":"1410","volume":"11","author":"Freeman","year":"2012","unstructured":"Freeman SA, Moon SD, Spencer JM (2012) Clindamycin phosphate 1.2\u2009% and tretinoin 0.025\u2009% gel for rosacea: summary of a placebo-controlled, double-blind trial. J Drugs Dermatol 11:1410\u20131414","journal-title":"J Drugs Dermatol"},{"key":"2518_CR25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1067\/mjd.2001.114739","volume":"44","author":"Goldman","year":"2001","unstructured":"Goldman D (2001) Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 44:995\u2013998","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR26","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/S0151-9638(11)70093-X","volume":"138","author":"Guerrero","year":"2011","unstructured":"Guerrero D (2011) Dermocosmetic management of the red face and rosacea. Ann Dermatol Venereol 138(Suppl 3):S215\u2013S218","journal-title":"Ann Dermatol Venereol"},{"key":"2518_CR27","unstructured":"Hebra F von (1856\u20131876) Atlas der Hautkrankheiten. Akademie der Wissenschaften, Wien"},{"key":"2518_CR28","unstructured":"Hildegard von Bingen (1989) Heilwissen (\u00fcbersetzt von M. Pawlik). Herder\/Spektrum, Freiburg Basel Wien"},{"key":"2518_CR29","first-page":"627","volume":"10","author":"Jackson","year":"2011","unstructured":"Jackson JM, Pelle M (2011) Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance. J Drugs Dermatol 10:627\u2013633","journal-title":"J Drugs Dermatol"},{"key":"2518_CR30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","volume":"22","author":"Karabulut","year":"2008","unstructured":"Karabulut AA, Izolserel B, Eksioglu HM (2008) A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1\u2009% for papulopustular rosacea. J Eur Acad Dermatol Venereol 22:729\u2013734","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2518_CR31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1346-8138.2011.01223.x","volume":"38","author":"Kim","year":"2011","unstructured":"Kim MB, Kim GW, Park HJ et al (2011) Pimecrolimus 1\u2009% cream for the treatment of rosacea. J Dermatol 38:1135\u20131139","journal-title":"J Dermatol"},{"key":"2518_CR32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","volume":"35","author":"Koca","year":"2010","unstructured":"Koca R, Altinyazar HC, Ankarali H et al (2010) A comparison of metronidazole 1\u2009% cream and pimecrolimus 1\u2009% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial. Clin Exp Dermatol 35:251\u2013256","journal-title":"Clin Exp Dermatol"},{"key":"2518_CR33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","volume":"205","author":"Kocak","year":"2002","unstructured":"Kocak M, Yagli S, Vahapoglu G, Eksioglu M (2002) Permethrin 5\u2009% cream versus metronidazole 0.75\u2009% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology 205:265\u2013270","journal-title":"Dermatology"},{"key":"2518_CR34","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","volume":"111","author":"Koczulla","year":"2003","unstructured":"Koczulla R, Degenfeld G von, Kupatt C et al (2003) An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18. J Clin Invest 111:1665\u20131672","journal-title":"J Clin Invest"},{"key":"2518_CR35","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1468-3083.2009.03167.x","volume":"23","author":"Korting","year":"2009","unstructured":"Korting HC, Schollmann C (2009) Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 23:876\u2013882","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2518_CR36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archderm.1974.01630100075019","volume":"110","author":"Leyden","year":"1974","unstructured":"Leyden JJ, Thew M, Kligman AM (1974) Steroid rosacea. Arch Dermatol 110:619\u2013622","journal-title":"Arch Dermatol"},{"key":"2518_CR37","first-page":"11","volume":"73","author":"Leyden","year":"2004","unstructured":"Leyden JJ, Thiboutot D, Shalita A (2004) Photographic review of results from a clinical study comparing benzoyl peroxide 5\u2009%\/clindamycin 1\u2009% topical gel with vehicle in the treatment of rosacea. Cutis 73(6 Suppl):11\u201317","journal-title":"Cutis"},{"key":"2518_CR38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.142.8.1047","volume":"142","author":"Liu","year":"2006","unstructured":"Liu RH, Smith MK, Basta SA, Farmer ER (2006) Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol 142:1047\u20131052","journal-title":"Arch Dermatol"},{"key":"2518_CR39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000071800","volume":"207","author":"L\u00fcbbe","year":"2003","unstructured":"L\u00fcbbe J, Stucky L, Saurat J-H (2003) Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1\u2009% pimecrolimus cream. Dermatology 207:205\u2013207","journal-title":"Dermatology"},{"key":"2518_CR40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","volume":"40","author":"Maddin","year":"1999","unstructured":"Maddin S (1999) A comparison of topical azelaic acid 20\u2009% cream and topical metronidazole 0.75\u2009% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 40:961\u2013965","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00128071-200001030-00007","volume":"1","author":"McClellan","year":"2000","unstructured":"McClellan KJ, Noble S (2000) Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 1:191\u2013199","journal-title":"Am J Clin Dermatol"},{"key":"2518_CR42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.1983.tb04003.x","volume":"109","author":"Nielsen","year":"1983","unstructured":"Nielsen PG (1983) The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream. Br J Dermatol 109:122\u2013123","journal-title":"Br J Dermatol"},{"key":"2518_CR43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1346-8138.2004.tb00566.x","volume":"31","author":"\u00d6zt\u00fcrkcan","year":"2004","unstructured":"\u00d6zt\u00fcrkcan S, Ermertcan AT, Sahin MT, Afsar FS (2004) Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea. J Dermatol 31:610\u2013617","journal-title":"J Dermatol"},{"key":"2518_CR44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","volume":"51","author":"Pelle","year":"2004","unstructured":"Pelle MT, Crawford GH, James WD (2004) Rosacea: II. therapy. J Am Acad Dermatol 51:499\u2013512","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(76)92160-7","volume":"1","author":"Pye","year":"1976","unstructured":"Pye RJ, Burton JL (1976) Treatment of rosacea with metronidazole. Lancet 1:1211\u20131212","journal-title":"Lancet"},{"key":"2518_CR46","first-page":"540","volume":"116","author":"Roth","year":"1980","unstructured":"Roth W (1980) \u00dcber eine \u00f6rtliche Behandlung der Rosaceaartigen perioralen Dermatitis mit Metronidazol. Dt Dermatol 116:540","journal-title":"Dt Dermatol"},{"key":"2518_CR47","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","volume":"143","author":"Shanler","year":"2007","unstructured":"Shanler SD, Ondo AL (2007) Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol 143:1369\u20131371","journal-title":"Arch Dermatol"},{"key":"2518_CR48","first-page":"177","volume":"56","author":"Signore","year":"1995","unstructured":"Signore RJ (1995) A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea. Cutis 56:177\u2013179","journal-title":"Cutis"},{"key":"2518_CR49","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","volume":"48","author":"Thiboutot","year":"2003","unstructured":"Thiboutot DM, Thieroff-Ekerdt R, Graupe K (2003) Efficacy and safety of azelaic acid (15\u2009%) gel as a new treatment for papulopustular rosacea: results from 2 vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 48:836\u2013845","journal-title":"J Am Acad Dermatol"},{"key":"2518_CR50","first-page":"541","volume":"7","author":"Thiboutot","year":"2008","unstructured":"Thiboutot DM, Fleischer AB Jr, Del Rosso JQ et al (2008) Azelaic acid 15\u2009% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol 7:541\u2013546","journal-title":"J Drugs Dermatol"},{"key":"2518_CR51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1248\/cpb.60.583","volume":"60","author":"Tirnaksiz","year":"2012","unstructured":"Tirnaksiz F, Kayis A, Celebi N et al (2012) Preparation and evaluation of topical microemulsion system containing metronidazole for remission in rosacea. Chem Pharm Bull 60:583\u2013592","journal-title":"Chem Pharm Bull"},{"key":"2518_CR52","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","volume":"165","author":"Van","year":"2011","unstructured":"Van Zuuren EJ, Kramer SF, Carter BR et al (2011) Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review. Br J Dermatol 165:760\u2013781","journal-title":"Br J Dermatol"},{"key":"2518_CR53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000051380","volume":"199","author":"Vienne","year":"1999","unstructured":"Vienne MP, Ochando N, Borrel MT et al (1999) Retinaldehyde alleviates rosacea. Dermatology 199(Suppl 1):53\u201356","journal-title":"Dermatology"},{"key":"2518_CR54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200203050-00007","volume":"3","author":"Warner","year":"2002","unstructured":"Warner GT, Plosker GL (2002) Clindamycin\/benzoyl peroxide gel: a review of its use in the management of acne. Am J Clin Dermatol 3:349\u2013360","journal-title":"Am J Clin Dermatol"},{"key":"2518_CR55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","volume":"32","author":"Wilkin","year":"1993","unstructured":"Wilkin JK, De Witt S (1993) Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol 32:65\u201367","journal-title":"Int J Dermatol"},{"key":"2518_CR56","unstructured":"Willan R (1798) Description and treatment of cutaneous diseases. Johnson, London"},{"key":"2518_CR57","first-page":"3","volume":"77","author":"Wolf","year":"2006","unstructured":"Wolf JE Jr, Kerrouche N, Arsonnaud S (2006) Efficacy and safety of once-daily metronidazole 1\u2009% gel compared with twice-daily azelaic acid 15\u2009% gel in the treatment of rosacea. Cutis 77(Suppl 4):3\u201311","journal-title":"Cutis"},{"key":"2518_CR58","first-page":"73","volume":"79","author":"Wolf","year":"2007","unstructured":"Wolf JE Jr, Del Rosso JQ (2007) The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis 79:73\u201380","journal-title":"Cutis"},{"key":"2518_CR59","first-page":"317","volume":"5","author":"Yoo","year":"2006","unstructured":"Yoo J, Reid DC, Kimball AB (2006) Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter? J Drugs Dermatol 5:317\u2013319","journal-title":"J Drugs Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2518-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-012-2518-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2518-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T12:29:07Z","timestamp":1688300947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-012-2518-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2518"],"URL":"https:\/\/doi.org\/10.1007\/s00105-012-2518-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]}}}